Ex vivo noggin gene therapy inhibits bone formation in a mouse model of postoperative resynostosis

Plastic and Reconstructive Surgery

Volumn 123, Issue SUPPL.2S, 2009, Pages

  Huard, Johnny ^a   Cooper, Gregory M ^a   Usas, Arvydas ^a   Olshanski, Anne ^a   Mooney, Mark P ^a   Losee, Joseph E ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GREEN FLUORESCENT PROTEIN; NOGGIN; BONE MORPHOGENETIC PROTEIN; CARRIER PROTEIN; GROWTH INHIBITOR; NOGGIN PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; EX VIVO STUDY; GENE THERAPY; HEALING; HISTOPATHOLOGY; HYPOTHESIS; MALE; MOUSE; NONHUMAN; OSSIFICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESYNOSTOSIS; STATISTICAL SIGNIFICANCE; SUTURE; ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; PLASTIC SURGERY; SYNOSTOSIS; WOUND HEALING;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CARRIER PROTEINS; CELLS, CULTURED; CRANIOSYNOSTOSES; DISEASE MODELS, ANIMAL; GENE THERAPY; GROWTH INHIBITORS; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OSTEOGENESIS; RECONSTRUCTIVE SURGICAL PROCEDURES; SYNOSTOSIS; WOUND HEALING;

EID: 61749103634     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318191c05b     Document Type: Conference Paper

References (51)

1. Enlow DH. Handbook of Facial Growth. Philadelphia: Saunders; 1990.
2. Cohen MM Jr. Epidemiology of Craniosynostosis. New York: Oxford University Press; 2000.
3. Hudgins RJ, Cohen SR, Burstein FD, et al. Multiple suture synostosis and increased intracranial pressure following repair of single suture, nonsyndromal craniosynostosis. Cleft Palate Craniofac J. 1998;35:167-172.
4. Renier D. Intracranial pressure in craniosynostosis: Pre- and postoperative recordings. Correlation with functional results. In Persing JA, Edgerton MT, Jane JA, eds. Scientific Foundations and Surgical Treatment of Craniosynostosis. Baltimore: Williams & Wilkins; 1989:263-269.
5. Campbell JW, Albright AL, Losken HW, et al. Intracranial hypertension after cranial vault decompression for cranio-synostosis. Pediatr Neurosurg. 1995;22:270-273.
6. Mooney MP, Siegel MI, Burrows AM, et al. A rabbit model of human familial, nonsyndromic unicoronal suture synostosis: II. Intracranial contents, intracranial volume, and intracranial pressure. Childs Nerv Syst. 1998;14:247-255.
7. Mooney MP, Fellows-Mayle W, Losken HW, et al. Increased intracranial pressure after coronal suturectomy in cranio-synostotic rabbits. J Craniofac Surg. 1999;10:104-110.
8. Camfield PR, Camfield CS, Cohen MM Jr. Neurosurgical aspects of craniosynostosis. In Cohen MM Jr, MacLean RE, eds. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford University Press; 2000:177-183.
9. Fellows-Mayle WK, Mooney MP, Losken HW, et al. Age-related changes in intracranial pressure in rabbits with uncorrected familial coronal suture synostosis. Cleft Palate Craniofac J. 2000;37:370-378.
10. Fellows-Mayle WK, Mitchell R, Losken HW, Bradley J, Siegel MI, Mooney MP Intracranial pressure changes in craniosyn-ostotic rabbits. Plast Reconstr Surg. 2004;113:557-565.
11. Gault DT, Renier D, Marchac D, Jones BM. Intracranial pressure and intracranial volume in children with cranio-synostosis. Plast Reconstr Surg. 1992;90:377-381.
12. Singhal VK, Mooney MP, Burrows AM, et al. Age related changes in intracranial volume in rabbits with craniosynos-tosis. Plast Reconstr Surg. 1997;100:1121-1128.
13. Jabs EW. Genetic etiologies of craniosynostosis. In Mooney MP, Siegel MI, eds. Understanding Craniofacial Anomalies: The Etiopathogenesis of Craniosynostoses and Facial Clefting. New York: Wiley; 2002:125-146.
14. Marsh JL, Vannier MW. Comprehensive Care for Craniofacial Deformities. St. Louis: Mosby; 1985.
15. Persing JA, Jane JA. Neurosurgical treatment of craniosyn-ostosis. In Cohen MM Jr, MacLean RE, eds. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford University Press; 2000:209-227.
16. Marchac D, Renier D. Craniofacial Surgery for Craniosynostosis. Boston: Little, Brown; 1982.
17. Posnick JC. Craniofacial and Maxillofacial Surgery in Children and Young Adults. Vols. 1 and 2. Philadelphia: Saunders; 2000.
18. Posnick JC. Craniosynostosis and the craniofacial dysostosis syndromes: Current surgical management. In Cohen MM Jr, MacLean RE, eds. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford University Press; 2000:269-291.
19. Warren SM, Longaker MT. The pathogenesis of craniosyn-ostosis in the fetus. Yonsei Med J. 2001;42:646-659.
20. David JD, Poswillo D, Simpson D. The Craniosynostoses: Causes, Natural History, and Management. Berlin: Springer-Verlag; 1982.
21. Turvey TA, Vig KWL, Fonseca RJ, eds. Facial Clefts and Cra-niosynostosis: Principles and Management. Philadelphia: Saunders; 1996.
22. Tessier P. Craniofacial surgery in syndromic craniosynosto-sis. In Cohen MM Jr, MacLean RE, eds. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford University Press; 2000:228-269.
23. Panchal J, Uttchin V. Management of craniosynostosis. Plast Reconstr Surg. 2003;111:2032-2048.
24. Norwood CW, Alexander E Jr, Davis CH Jr, Kelly DR Jr. Recurrent and multiple suture closures after craniectomy for craniosynostosis. J Neurosurg. 1974;41:715-719.
25. Hassler W, Zentner J. Radical osteoclastic craniectomy in sagittal synostosis. Neurosurgery 1990;27:539-543.
26. Fatah MF, Ermis I, Poole MD, Shun-Shin GA. Prevention of cranial reossification after surgical craniectomy. J Craniofac Surg. 1992;3:170-172.
27. Drake DB, Persing JA, Berman DE, Ogle RC. Calvarial deformity regeneration following subtotal craniectomy for cra-niosynostosis: A case report and theoretical implications. J Craniofac Surg. 1993;4:85-89; discussion 90.
28. McCarthy JG, Glasberg SB, Cutting CB, et al. Twenty-year experience with early surgery for craniosynostosis: I. Isolated craniofacial synostosis. Results and unsolved problems. Plast Reconstr Surg. 1995;96:272-283.
29. Pollack IF, Losken HW, Biglan AW. Incidence of increased intracranial pressure after early surgical treatment of syn-dromic craniosynostosis. Pediatr Neurosurg. 1996;24:202-209.
30. Kirkpatrick WN, Koshy CE, Waterhouse N, Fauvel NJ, Carr RJ, Peterson DC. Paediatric transcranial surgery: A review of 114 consecutive procedures. Br J Plast Surg. 2002;55:561-564.
31. Mommaerts MY, Staels PF, Casselman JW. The faith of a coronal suture grafted onto midline synostosis inducing dura and deprived from tensile stress. Cleft Palate Craniofac J. 2001; 38:533-537.
32. Babler WJ, Persing JA. Experimental alteration of cranial suture growth: Effects on the neurocranium, basicranium, and midface. In Sarnat BG, ed. Factors and Mechanisms Influencing Bone Growth. New York: Alan R. Liss; 1982:333-345.
33. Mooney MP, Burrows AM, Smith TD, et al. Correction of coronal suture synostosis using suture and dura mater allo-grafts in rabbits with familial craniosynostosis. Cleft Palate Craniofac J. 2001;38:206-225.
34. Moreira-Gonzalez A, Jackson IT, Miyawaki T, Barakat K, Di-Nick V. Clinical outcome in cranioplasty: Critical review in long-term follow-up. J Craniofac Surg. 2003;14:144-153.
35. Williams JK, Cohen SR, Burstein FD, Hudgins R, Boydston W, Simms C. A longitudinal, statistical study of reoperation rates in craniosynostosis. Plast Reconstr Surg. 1997;100:305-310.
36. Urist MR. Bone: Formation by autoinduction. Science 1965; 150:893-899.
37. Canalis E, Economides AN, Gazzerro E. Bone morphoge-netic proteins, their antagonists, and the skeleton. Endocr Rev. 2003;24:218-235.
38. Spector JA, Luchs JS, Mehrara BJ, Greenwald JA, Smith LP, Longaker MT. Expression of bone morphogenetic proteins during membranous bone healing. Plast Reconstr Surg. 2001; 107:124-134.
39. Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996;86:599-606.
40. Groppe J, Greenwald J, Wiater E, et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 2002;420:636-642.
41. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators. Dev Biol. 2002;250:231-250.
42. Aspenberg P, Jeppsson C, Economides AN. The bone mor-phogenetic proteins antagonist Noggin inhibits membranous ossification. J Bone Miner Res. 2001;16:497-500.
43. Glaser DL, Economides AN, Wang L, et al. In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg (Am.) 2003;85:2332-2342.
44. Hannallah D, Peng H, Young B., Usas A, Gearhart B, Huard J. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg (Am.) 2004;86:80-91.
45. Peng H, Usas A, Hannallah D, Olshanski A, Cooper GM, Huard J. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Mol Ther. 2005;12: 239-246.
46. Cooper GM, Curry C, Barbano TE, et al. Noggin inhibits postoperative resynostosis in craniosynostotic rabbits. J Bone Miner Res. 2007;22:1046-1054.
47. Qu-Petersen Z, Deasy B, Jankowski R, et al. Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol. 2002;157:851-864.
48. Lee JY, Qu-Petersen Z, Cao B, et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol. 2000;150:1085-1100.
49. Peng H, Usas A, Gearhart B, Young B, Olshansky A, Huard J. Development of a self-inactivating tet-on retroviral vector expressing bone morphogenetic protein 4 to achieve regulated bone formation. Mol Ther. 2004;9:885-894.
50. Peng H, Usas A, Gearhart B, Olshansky A, Shen HC, Huard J. Converse relationship between in vitro osteogenic differentiation and in vivo bone healing elicited by different populations of muscle-derived cells genetically engineered to express BMP4. J Bone Miner Res. 2004;19:630-641.
51. Peng H, Wright V, Usas A, et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest. 2002;110: 751-759.